Cargando…
B Vitamin and/or n-3 Fatty Acid Supplementation and Health-Related Quality of Life: Ancillary Findings from the SU.FOL.OM3 Randomized Trial
BACKGROUND: Despite growing attention to nutrition and quality of life in cardiovascular disease survivors, the impact of dietary factors according to disease type or to quality of life domain is poorly understood. We investigated the effects of B vitamin and/or n-3 fatty acid supplementation on hea...
Autores principales: | Andreeva, Valentina A., Latarche, Clotilde, Hercberg, Serge, Briançon, Serge, Galan, Pilar, Kesse-Guyot, Emmanuelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894946/ https://www.ncbi.nlm.nih.gov/pubmed/24465438 http://dx.doi.org/10.1371/journal.pone.0084844 |
Ejemplares similares
-
Baseline Plasma Fatty Acids Profile and Incident Cardiovascular Events in the SU.FOL.OM3 Trial: The Evidence Revisited
por: Fezeu, Léopold K., et al.
Publicado: (2014) -
The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics
por: Galan, Pilar, et al.
Publicado: (2008) -
MTHFR
677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial
por: Fezeu, Leopold K., et al.
Publicado: (2018) -
Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial
por: Galan, Pilar, et al.
Publicado: (2010) -
Alcohol Consumption in Midlife and Cognitive Performance Assessed 13 Years Later in the SU.VI.MAX 2 Cohort
por: Kesse-Guyot, Emmanuelle, et al.
Publicado: (2012)